This company listing is no longer active
5OT Stock Overview
Singapore Medical Group Limited operates medical clinics and provides general medical services in Singapore.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 5OT from our risk checks.
Singapore Medical Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.40 |
| 52 Week High | S$0.41 |
| 52 Week Low | S$0.28 |
| Beta | 0.62 |
| 1 Month Change | 0% |
| 3 Month Change | 9.72% |
| 1 Year Change | 31.67% |
| 3 Year Change | 31.67% |
| 5 Year Change | -34.71% |
| Change since IPO | 64.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5OT | SG Healthcare | SG Market | |
|---|---|---|---|
| 7D | 0% | 0.5% | 0.05% |
| 1Y | 31.7% | -24.0% | -5.9% |
Return vs Industry: 5OT exceeded the SG Healthcare industry which returned -6% over the past year.
Return vs Market: 5OT exceeded the SG Market which returned -2.8% over the past year.
Price Volatility
| 5OT volatility | |
|---|---|
| 5OT Average Weekly Movement | 2.9% |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in SG Market | 15.3% |
| 10% least volatile stocks in SG Market | 2.2% |
Stable Share Price: 5OT has not had significant price volatility in the past 3 months.
Volatility Over Time: 5OT's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 303 | Meng Deliang Beng | www.smg.sg |
Singapore Medical Group Limited operates medical clinics and provides general medical services in Singapore. The company operates through three segments: Health Business, Diagnostic & Aesthetics Business, and Others. The Health Business segment offers obstetrical and gynaecological services for the wellness of women; oncology services, including the prevention, diagnosis, and treatment of cancer, cancer screening and cancer genetic, and risk assessment; endocrinology services; general medicine and health screening services; cardiology services; and paediatrics services.
Singapore Medical Group Limited Fundamentals Summary
| 5OT fundamental statistics | |
|---|---|
| Market cap | S$192.12m |
| Earnings (TTM) | S$14.68m |
| Revenue (TTM) | S$105.26m |
13.1x
P/E Ratio1.8x
P/S RatioIs 5OT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5OT income statement (TTM) | |
|---|---|
| Revenue | S$105.26m |
| Cost of Revenue | S$60.83m |
| Gross Profit | S$44.43m |
| Other Expenses | S$29.75m |
| Earnings | S$14.68m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.03 |
| Gross Margin | 42.21% |
| Net Profit Margin | 13.95% |
| Debt/Equity Ratio | 1.5% |
How did 5OT perform over the long term?
See historical performance and comparison